- Home
- SWIN vs RVPH Comparison
SWIN vs RVPH Comparison
Compare SWIN & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWIN
- RVPH
- Stock Information
- Founded
- SWIN 2017
- RVPH 2006
- Country
- SWIN Hong Kong
- RVPH United States
- Employees
- SWIN N/A
- RVPH N/A
- Industry
- SWIN
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- SWIN
- RVPH Health Care
- Exchange
- SWIN Nasdaq
- RVPH Nasdaq
- Market Cap
- SWIN 32.1M
- RVPH 31.5M
- IPO Year
- SWIN 2023
- RVPH N/A
- Fundamental
- Price
- SWIN $3.06
- RVPH $0.36
- Analyst Decision
- SWIN
- RVPH Strong Buy
- Analyst Count
- SWIN 0
- RVPH 5
- Target Price
- SWIN N/A
- RVPH $9.00
- AVG Volume (30 Days)
- SWIN 292.8K
- RVPH 1.7M
- Earning Date
- SWIN 08-21-2025
- RVPH 08-13-2025
- Dividend Yield
- SWIN N/A
- RVPH N/A
- EPS Growth
- SWIN N/A
- RVPH N/A
- EPS
- SWIN N/A
- RVPH N/A
- Revenue
- SWIN $2,419,000.00
- RVPH N/A
- Revenue This Year
- SWIN N/A
- RVPH N/A
- Revenue Next Year
- SWIN $61.68
- RVPH N/A
- P/E Ratio
- SWIN N/A
- RVPH N/A
- Revenue Growth
- SWIN N/A
- RVPH N/A
- 52 Week Low
- SWIN $1.16
- RVPH $0.30
- 52 Week High
- SWIN $4.17
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- SWIN 79.41
- RVPH 27.45
- Support Level
- SWIN $1.57
- RVPH $0.72
- Resistance Level
- SWIN $3.48
- RVPH $0.83
- Average True Range (ATR)
- SWIN 0.26
- RVPH 0.07
- MACD
- SWIN 0.13
- RVPH -0.03
- Stochastic Oscillator
- SWIN 78.05
- RVPH 9.67
About SWIN Solowin Holdings
Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.